Form 4 for IDXX Idexx Laboratories
Accepted 2022-12-07 00:00:00 ET · period of report 2022-12-05 · accession 0001567619-22-021390 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-07 | 2022-12-05 | IDXX | JUNIUS DANIEL M | Dir | M - OptEx | $160.28 | +3,046 | 6,014 | +103% | +$488.2K |
| D | 2022-12-07 | 2022-12-05 | IDXX | JUNIUS DANIEL M | Dir | S - Sale+OE | $424.91 | -3,046 | 2,968 | -51% | -$1.29M |
| D | 2022-12-07 | 2022-12-05 | IDXX | JUNIUS DANIEL M | Dir | M - OptEx | — | -3,046 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-05 | M | A | 3,046 | $160.28 | 6,014 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-05 | S | D | 3,046 | $424.91 | 2,968 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2022-12-05 | M | D | 3,046 | — | 0 | D | $160.28 · — to 2027-05-02 | 3,046 Common Stock | (F2) Not applicable. (F1) Grant of option to buy 3,046 shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2018 annual meeting of shareholders, whichever event was earlier. |